Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma

SIMPLE SUMMARY: Glioblastoma (GBM) remains the most aggressive brain tumor. Treatment typically includes surgery and radio/chemotherapy, but in spite of intensive treatment, virtually all tumors recur within the time-frame of months with insufficient and unsuccessful second line options. This clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wouters, Roxanne, Bevers, Sien, Riva, Matteo, De Smet, Frederik, Coosemans, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793150/
https://www.ncbi.nlm.nih.gov/pubmed/33374542
http://dx.doi.org/10.3390/cancers13010019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793150/
https://www.ncbi.nlm.nih.gov/pubmed/33374542
http://dx.doi.org/10.3390/cancers13010019

Ejemplares similares